Phone: 959-333-0983
Phone: 959-333-0983
$54.99
This item has been third-party tested by accredited U.S. laboratories and confirmed to meet a minimum purity of 98% through rigorous verification standards.
BPC-157 is a synthetic peptide fragment derived from a naturally occurring gastric protein and is studied in laboratory settings for its role in cellular signaling and tissue response models.
Research involving BPC-157 focuses on its interaction with angiogenic, nitric oxide, and cytoprotective pathways in controlled experimental environments. This compound is supplied exclusively for scientific and analytical research use.
$54.99
Synthetic Pentadecapeptide Research Compound
BPC-157 is a synthetic peptide supplied exclusively for laboratory and analytical research purposes. This compound is studied in controlled research environments for its role in peptide signaling research, cellular communication models, and experimental pathway investigations.
Each batch of BPC-157 is independently third-party tested to verify identity and purity, supporting accuracy and reproducibility in scientific research applications.
BPC-157 is studied in laboratory and preclinical research environments to better understand how short-chain peptides interact with biological signaling systems. Researchers examine this compound to explore:
As a synthetic research peptide, BPC-157 serves as a tool compound for investigating peptide signaling characteristics in controlled experimental systems.
In experimental models, BPC-157 is examined for its interaction with cellular signaling pathways and peptide-responsive molecular systems. Research focuses on signal modulation, pathway interaction mapping, and cellular response observation within controlled laboratory environments.
These investigations are mechanistic and exploratory and do not imply healing, repair, injury recovery, gastrointestinal support, or therapeutic outcomes.
This BPC-157 peptide supplied by ResearchChemical.com is produced under controlled synthesis conditions and verified per batch to meet stated specifications.
Product-specific attributes include:
This information is specific to the product offered on this page and should not be generalized across other peptide listings.
Research involving BPC-157 has explored its interaction with several cellular signaling systems, particularly in controlled experimental models.
BPC-157 has been examined in laboratory settings for its interaction with angiogenic signaling pathways. These studies focus on how peptide fragments influence cellular communication related to vascular signaling, rather than on functional outcomes.
Another area of research interest involves the nitric oxide (NO) signaling system. Nitric oxide plays a key role in cellular communication, and BPC-157 has been studied for how it may modulate NO-related signaling cascades under experimental conditions.
BPC-157 has also been included in research models examining cytoprotective signaling mechanisms, which are involved in maintaining cellular integrity during experimental stress conditions. These investigations are conducted strictly within laboratory and preclinical research contexts.
Research Chemical products are third-party tested by MZ Biolabs, an independent U.S. laboratory.
Each batch is analyzed to confirm purity, identity, and compliance with stated specifications.
Each Certificate of Analysis includes:
By purchasing from ResearchChemical.com, you acknowledge that you are acquiring research chemicals intended solely for scientific investigation.
These products:
ResearchChemical.com assumes no liability for misuse, improper handling, or use outside of controlled laboratory settings.
BPC 157 peptide has shown positive findings in testing and laboratory experimentation for its potential to promote wound healing, blood vessel growth, and tissue repair, including effects on the gastrointestinal tract and nervous system. All effects including those on the digestive tract and blood vessels are currently under study.
BPC 157 peptide is a synthetic compound composed of amino acids. It is a partial sequence of the parent molecule, Body Protection Compound (BPC).
BPC 157 peptide is considered well-tolerated, with no reported side effects in lab research and animal models. However, further clinical trials are needed to fully establish its safety profile for human consumption.
No, there is no evidence to suggest that BPC 157 suppresses testosterone. Instead, research indicates its positive effects on the wound healing process and tissue repair that is currently being studied by researchers and institutions.
Each batch is third-party tested. COAs confirm identity, purity, and concentration using validated analytical methods. We employ tamper-evident, UV-resistant packaging and clear labeling to support traceability.
No. As a research supplier, we do not provide any dosing, cycle, or clinical guidance. BPC-157 is not for human consumption.
The literature is predominantly preclinical (in vitro and animal studies) evaluating regenerative effects, angiogenesis (e.g., VEGF-related pathways), collagen synthesis, and GI mucosal protection. Clinical data remain limited; systematic reviews continue to highlight the need for robust, controlled human studies.
Yes. BPC-157 is listed among prohibited substances by the World Anti Doping Agency (WADA). Athletes who use peptide hormones risk testing positive under anti-doping controls.
No. BPC-157 is not FDA-approved and is not authorized for clinical use or as a dietary supplement. It is supplied strictly for research purposes.
Buy BPC-157 Peptide With Quality Guaranteed from Research Chemical
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
Research Chemical products are third-party tested by MZ Biolabs, an independent U.S. laboratory.
Each batch is analyzed to confirm purity, identity, and compliance with stated specifications.
Each Certificate of Analysis includes:
By purchasing from ResearchChemical.com, you acknowledge that you are acquiring research chemicals intended solely for scientific investigation.
These products:
ResearchChemical.com assumes no liability for misuse, improper handling, or use outside of controlled laboratory settings.
1. Sikiric P, Seiwerth S, Grabarevic Z, et al. BPC 157’s effect on healing. Journal of Physiology and Pharmacology. 2009 Dec;60(Suppl 7): Suppl 2: 191-6. PMID: 20572349.
2. Chang CH, Tsai WC, Lin MS, et al. Effects of pentadecapeptide BPC 157 on tendon healing in a rat model. Journal of Orthopaedic Research. 2011 Aug;29(8): 1174-80. doi: 10.1002/jor.21367.
3. Klicek R, Sever M, Radic B, et al. Gastric pentadecapeptide BPC 157 accelerates healing of transected rat Achilles tendon and in vitro stimulates tendocytes growth. Journal of Orthopaedic Research. 2003;21(6):976-83. doi: 10.1016/S0736-0266(03)00081-1.
4. Mogoşanu, G. D., & Grumezescu, A. M. (2014). Natural and synthetic polymers for wounds and burns dressing. International journal of pharmaceutics, 463(2), 127-136.
5. Krivic A, Anic T, Seiwerth S, et al. Achilles Detachment in Rat and Stable Gastric Pentadecapeptide BPC 157: Promoted Tendon-to-Bone Healing and Opposed Corticosteroid Adverse Effects. Journal of Orthopaedic Research. 2006 Jun;24(6):982-93. doi: 10.1002/jor.20096.
6. Chang, C. H., Tsai, W. C., Lin, M. S., Hsu, Y. H., & Pang, J. H. S. (2011). The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration. Journal of applied physiology, 110(3), 774-780.
7. Duzel, A., Vlainic, J., Antunovic, M., Malekinusic, D., Vrdoljak, B., Samara, M., … & Sikiric, P. (2017). Stable gastric pentadecapeptide BPC 157 in the treatment of colitis and ischemia and reperfusion in rats: New insights. World Journal of Gastroenterology, 23(48), 8465.
8. Sikiric P, et al. Stable gastric pentadecapeptide BPC 157 in the treatment of colitis and ischemia and reperfusion in rats: new insights. World Journal of Gastroenterology. 2017;23(48): 8465-8488. doi: 10.3748/wjg.v23.i48.8465.
9. Sikiric P, et al. Stable gastric pentadecapeptide BPC 157 in trials for inflammatory bowel disease (PL14736) (gep- bpc-157). Current Pharmaceutical Design. 2018;24(2): 190-195. doi: 10.2174/1381612823666170829095955.
10. Stupnisek M, et al. Pentadecapeptide BPC 157, in clinical trials as a therapy for inflammatory bowel disease (PL14736), is effective in the healing of colocutaneous fistulas in rats: role of the nitric oxide-system. Journal of Pharmacological Sciences. 2017;133(4): 201-208. doi: 10.1016/j.jphs.2017.07.009.
Join our insider list for the latest research insights, product releases, and special offers—delivered straight to your inbox.